The global Tissue Diagnostics market is segmented on the basis of product, technology, disease, end user and region. The growing incidence of cancer along with a rapidly aging population, technological advancements in tissue diagnostics techniques, and increasing healthcare expenditure are key factors driving the growth of the tissue diagnostics market.
Based on product, the tissue diagnostics market is segmented primarily into consumables and instruments, of which consumables held the leading share in 2017. Their wide use in processing tissue samples and their repeated consumption in tissue diagnostics has ensured their dominance in the market. Instruments, on the other hand, are typically one-time purchases and thus hold a smaller market share.
Download PDF Brochure@
By technology, the market is classified into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. The immunohistochemistry segment is estimated to account for the largest share of the global tissue diagnostics market during the next five years. Growth in the IVD (in vitro diagnostics) market and the large number of products based on this technology are driving the growth of this market.
On the basis of end user, the market is segmented into hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users. The hospitals segment is estimated to account for the largest share of the global market during the forecast period. Growth in the number of hospitals coupled with better accessibility and availability of test results in hospitals are major factors driving the growth of this end-user segment.
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=1063949
The tissue diagnostics market is segmented into four major regions—North America, Europe, Asia, and the Rest of the World (RoW). North America was the largest market for tissue diagnostics in 2017, due to several factors such as the strong presence of market players in the region, the growing geriatric population and chronic disease incidence, and easy access to healthcare services.
The Tissue Diagnostics market is dominated by big players such as F. Hoffman-La Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott Laboratories (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan, Abcam (UK), Becton, Dickinson and Company (US), and QIAGEN (Netherlands).